Johnson & JohnsonJNJCOMMENTFeb 04, 2015Stock price when the opinion was issued
As of Jun 09, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
Great year, so valuation has expanded. Shedding lower-growth businesses, focusing on medical devices and pharma. Those 2 areas are higher-margin businesses, so success would mean multiple could continue to expand. Legal overhang diminished.
If you already own it, you can hold it for dividend growth and potential upside. If you don't own, buy via an ETF.
Tough one. Spun out KVUE, which is in a nice space, but the stock's done nothing. JNJ is now more drugs and medical devices, and its stock's done nothing either. Drug companies are difficult to own, really have to do your homework.
He doesn't want to recommend selling. Drug pipeline sounds good. Good earnings release, and has a bit of earnings momentum behind it. So might not be the time to sell. Yield is ~3%.
High in 2022, series of lower highs and lower lows since then. Only positive is that on the most recent pullback it pulled back to a higher low. If you own it as one position among many, you probably won't lose a bunch of $$. Doesn't see it being a leading stock in the near term.
Lean into companies that are economically sensitive with pricing power; if their costs go up tomorrow, they can raise prices the next day.
A terrific company. A worldwide seller of a huge number of very popular brands. However, being a worldwide seller is not necessarily to your advantage if you are an American company, because you are repatriating revenues and profits in other currencies, and the US$ is beating all the other currencies into the ground. All the US multinationals are missing on their earnings because of this. When you Buy this, you are getting a tremendous stream of products and a dividend record that is 2nd to none as well as a record of dividend increases. If you are a long-term buyer, you buy it for the dividend and the increasing dividend.